Average Co-Inventor Count = 3.30
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Synergy Pharmaceuticals, Inc. (8 from 34 patents)
2. Bausch Health Ireland Limited (6 from 42 patents)
3. Other (5 from 832,891 patents)
4. Orapharma, Inc. (3 from 12 patents)
5. Aventis Pharmaceuticals Inc. (1 from 207 patents)
23 patents:
1. 12146003 - Ultra-pure agonists of guanylate cyclase C, method of making and using same
2. 11834521 - Ultra-pure agonists of guanylate cyclase C, method of making and using same
3. 11319346 - Ultra-pure agonists of guanylate cyclase C, method of making and using same
4. 11142549 - Ultra-pure agonists of guanylate cyclase C, method of making and using same
5. 10745441 - Ultra-pure agonists of guanylate cyclase C, method of making and using same
6. 10421787 - Process of preparing guanylate cyclase C agonisys
7. 10232011 - Formulations of guanylate cyclase C agonists and methods of use
8. 10034836 - Formulations of guanylate cyclase C agonists and methods of use
9. 10011637 - Ultra-pure agonists of guanylate cyclase C, method of making and using same
10. 9925231 - Formulations of guanylate cyclase C agonists and methods of use
11. 9919024 - Formulations of guanylate cyclase C agonists and methods of use
12. 9616097 - Formulations of guanylate cyclase C agonists and methods of use
13. 9610321 - Formulations of guanylate cyclase C agonists and methods of use
14. 9580471 - Process of preparing guanylate cyclase C agonists
15. 8828177 - Reflected light glare minimization for athletic contest participants while providing a non verbal communication